Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8951 | 1134 | 34.5 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
192 | 20771 | JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY//RAPID COMMUNICATIONS IN MASS SPECTROMETRY//INTERNATIONAL JOURNAL OF MASS SPECTROMETRY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RIEVE L S MASS SPE OMETRY | Address | 10 | 35% | 2% | 22 |
2 | OLIGONUCLEOTIDE SEQUENCING | Author keyword | 8 | 100% | 0% | 5 |
3 | 90T | Address | 6 | 71% | 0% | 5 |
4 | GUANGZHOU MASS SPE OMETRY | Address | 5 | 63% | 0% | 5 |
5 | BASE SPECIFIC CLEAVAGE | Author keyword | 4 | 75% | 0% | 3 |
6 | DNA SEQUENCING CHEM BIOL | Address | 4 | 56% | 0% | 5 |
7 | GAS PHASE DISSOCIATION | Author keyword | 3 | 50% | 0% | 5 |
8 | OLIGONUCLEOTIDE ANALYSIS | Author keyword | 3 | 60% | 0% | 3 |
9 | ION PAIR REVERSED PHASE LIQUID CHROMATOGRAPHY | Author keyword | 3 | 42% | 0% | 5 |
10 | ISIS PHARMACEUT | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MULTIPLY CHARGED OLIGONUCLEOTIDES | 73 | 88% | 3% | 35 |
2 | ION STABILITY | 58 | 92% | 2% | 23 |
3 | THERAPEUTIC OLIGONUCLEOTIDES | 51 | 91% | 2% | 21 |
4 | PHASE CAPTURABLE DIDEOXYNUCLEOTIDES | 34 | 93% | 1% | 13 |
5 | ANTISENSE DNA OLIGONUCLEOTIDES | 30 | 100% | 1% | 12 |
6 | METHYLPHOSPHONATE OLIGODEOXYRIBONUCLEOTIDES | 23 | 100% | 1% | 10 |
7 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | 17 | 79% | 1% | 11 |
8 | 50 MER | 17 | 75% | 1% | 12 |
9 | FRAGMENTATION MECHANISMS | 15 | 39% | 3% | 31 |
10 | MULTIPLY DEPROTONATED RNA | 15 | 88% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gas-phase fragmentation of oligonucleotide ions | 2004 | 89 | 157 | 73% |
MALDI-TOF mass spectrometry - A versatile tool for high-performance DNA analysis | 2004 | 87 | 70 | 63% |
Chromatographic methods for the determination of therapeutic oligonucleotides | 2012 | 16 | 113 | 52% |
Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry | 2000 | 142 | 60 | 53% |
Genotyping single nucleotide polymorphisms by mass spectrometry | 2002 | 86 | 178 | 63% |
Analysis of nucleic acids by FTICR MS | 2005 | 60 | 92 | 67% |
Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides | 2007 | 31 | 48 | 56% |
Mass spectrometry of nucleic acids | 1996 | 194 | 142 | 68% |
Bioanalytical LC-MS of therapeutic oligonucleotides | 2011 | 12 | 85 | 55% |
DNA analysis by MALDI-TOF mass spectrometry | 2004 | 66 | 28 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RIEVE L S MASS SPE OMETRY | 10 | 35% | 1.9% | 22 |
2 | 90T | 6 | 71% | 0.4% | 5 |
3 | GUANGZHOU MASS SPE OMETRY | 5 | 63% | 0.4% | 5 |
4 | DNA SEQUENCING CHEM BIOL | 4 | 56% | 0.4% | 5 |
5 | ISIS PHARMACEUT | 2 | 67% | 0.2% | 2 |
6 | ADV CHEM TECHNOL LASER INDUCED REACT | 1 | 100% | 0.2% | 2 |
7 | CHEM ENGN PHARMACOL | 1 | 100% | 0.2% | 2 |
8 | FNES | 1 | 50% | 0.2% | 2 |
9 | MACROMOL STRUCT DYNAM | 1 | 50% | 0.2% | 2 |
10 | MASSESPEKTROMETRI SENTER TEORETISK BEREGNINGSB | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000172794 | HYBRIDIZATION RATE//AMORPHA GEORGIANA//ANTISENSE DRUG |
2 | 0.0000135166 | SALDI//MALDI//IONIC LIQUID MATRICES |
3 | 0.0000101377 | NON COVALENT COMPLEXES//NONCOVALENT COMPLEX//NONCOVALENT COMPLEXES |
4 | 0.0000100076 | DNA POOLING//DNA POOL//PYROSEQUENCING TECHNOLOGY |
5 | 0.0000083251 | FT ICR//FTMS//EXTERNAL ION SOURCE |
6 | 0.0000080770 | URINARY NUCLEOSIDES//URINARY MODIFIED NUCLEOSIDES//MODIFIED NUCLEOSIDES |
7 | 0.0000076353 | CHARGE REMOTE FRAGMENTATION//FAST ATOM BOMBARDMENT//INTERNAL CALIBRANT |
8 | 0.0000066551 | ION ION REACTIONS//ELECTRON CAPTURE DISSOCIATION//ELECTRON TRANSFER DISSOCIATION |
9 | 0.0000059120 | QUEUINE//TRNA MODIFICATION//RNA MODIFICATION |
10 | 0.0000054635 | H PHOSPHONATES//OLIGONUCLEOTIDE SYNTHESIS//UNIVERSAL SOLID SUPPORT |